Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"LARP4B-DT" (LARP4B divergent transcript) does not correspond to a protein, receptor, or typical drug target but instead likely refers to a predicted or uncharacterized long noncoding RNA originating from the LARP4B genetic locus. LARP4B itself is a well-known RNA-binding protein involved in mRNA stabilization, but there is no scientific support for "LARP4B-DT" as a molecular target or therapeutic entity[1][2][4]. The use of the term "-DT" (divergent transcript) is sometimes seen in genomic annotation databases to denote noncoding RNAs transcribed adjacent to, but on the opposite strand from, a protein-coding gene. However, such transcripts are not generally considered drug targets nor reported in the context of known receptor/target biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LARP4B divergent transcript.